NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 270 filers reported holding NEKTAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $149,000 | -68.3% | 3,050 | -31.1% | 1.21% | -57.7% |
| Q1 2018 | $470,000 | +19.9% | 4,425 | -32.5% | 2.86% | +16.0% |
| Q4 2017 | $392,000 | +59.3% | 6,560 | -36.0% | 2.46% | +447.3% |
| Q3 2017 | $246,000 | +23.0% | 10,250 | 0.0% | 0.45% | +18.4% |
| Q2 2017 | $200,000 | +4.2% | 10,250 | +25.0% | 0.38% | -2.3% |
| Q1 2017 | $192,000 | +90.1% | 8,200 | 0.0% | 0.39% | +81.8% |
| Q4 2016 | $101,000 | -99.9% | 8,200 | 0.0% | 0.21% | +8.6% |
| Q3 2016 | $140,876,000 | +122400.9% | 8,200 | +1.2% | 0.20% | +109.6% |
| Q2 2016 | $115,000 | -99.9% | 8,105 | +35.0% | 0.09% | +80.8% |
| Q1 2016 | $82,568,000 | +81650.5% | 6,005 | 0.0% | 0.05% | -14.8% |
| Q4 2015 | $101,000 | – | 6,005 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |